No photo of Ali M Elbireer

View Scopus Profile

Ali M Elbireer

Research Associate

20102018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 8 Similar Profiles
Uganda Medicine & Life Sciences
HIV Medicine & Life Sciences
Reverse Transcriptase Inhibitors Medicine & Life Sciences
Point-of-Care Systems Medicine & Life Sciences
Clinical laboratories Chemical Compounds
Nevirapine Medicine & Life Sciences
Viral Load Medicine & Life Sciences
Lopinavir Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2018

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team Jan 1 2018 In : The Lancet infectious diseases. 18, 1, p. 47-57 11 p.

Research output: Contribution to journal › Article

Lopinavir
Reverse Transcriptase Inhibitors
Protease Inhibitors
Nucleosides
Randomized Controlled Trials

Test Cost and Test Accuracy in Clinical Laboratories in Kampala, Uganda

Amukele, T. K., Jones, R. & Elbireer, A. Apr 25 2018 In : American journal of clinical pathology. 149, 6, p. 522-529 8 p.

Research output: Contribution to journal › Article

Uganda
Costs and Cost Analysis
Syphilis
Malaria
Chorionic Gonadotropin

Multi-country validation of SAMBA - A novel molecular point-of- care test for HIV-1 detection in resource–limited setting

Ondiek, J., Namukaya, Z., Mtapuri-Zinyowera, S., Balkan, S., Elbireer, A., Ushiro Lumb, I., Kiyaga, C., Goel, N., Ritchie, A., Ncube, P., Omuomu, K., Ndiege, K., Kekitiinwa, A., Mangwanya, D., Fowler, M. G., Nadala, L. & Lee, H. Jun 9 2017 (Accepted/In press) In : Journal of Acquired Immune Deficiency Syndromes.

Research output: Contribution to journal › Article

Point-of-Care Systems
HIV-1
Early Diagnosis
Hematologic Tests
HIV Infections

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial

Paton, N. I. , Kityo, C. , Thompson, J. , Nankya, I. , Bagenda, L. , Hoppe, A. , Hakim, J. , Kambugu, A. , van Oosterhout, J. J. , Kiconco, M. , Bertagnolio, S. , Easterbrook, P. J. , Mugyenyi, P. , Walker, A. S. , Agweng, E. , Awio, P. , Bakeinyaga, G. , Isabirye, C. , Kabuga, U. , Kasuswa, S. & 30 others Katuramu, M., Kityo, C., Kiweewa, F., Kyomugisha, H., Lutalo, E., Mugyenyi, P., Mulima, D., Musana, H., Musitwa, G., Musiime, V., Ndigendawan, M., Namata, H., Nkalubo, J., Labejja, P. O., Okello, P., Olal, P., Pimundu, G., Segonga, P., Ssali, F., Tamale, Z., Tumukunde, D., Namala, W., Byaruhanga, R., Kayiwa, J., Tukamushaba, J., Abunyang, S., Eram, D., Denis, O., Lwalanda, R. & Elbireer, A. Aug 1 2017 In : The Lancet HIV. 4, 8, p. e341-e348

Research output: Contribution to journal › Article

Reverse Transcriptase Inhibitors
Nucleosides
Public Health
Protease Inhibitors
Therapeutics

Scaling up HIV viral load - Lessons from the large-scale implementation of HIV early infant diagnosis and CD4 testing

Peter, T., Zeh, C., Katz, Z., Elbireer, A., Alemayehu, B., Vojnov, L., Costa, A., Doi, N. & Jani, I. Nov 1 2017 In : Journal of the International AIDS Society. 20, p. 9-15 7 p.

Research output: Contribution to journal › Review article

Viral Load
Early Diagnosis
HIV
Point-of-Care Systems
Information Systems